Expression and clinical significance of bcl-2/bax protein in benign and malignant lesions of the gallbladder

郝秀原,石景森,周连锁,王作仁,卢云,田和平,韩梅荣
DOI: https://doi.org/10.3969/j.issn.1671-8259.2000.01.012
2000-01-01
Abstract:To explore the functioning of bcl-2 gene family in biological behavior in benign and malignant lesions of the gallbladder, bcl-2 and Bax protein levels were assessed by immunohistochemical methods (S-P) in 16 specimens of cholecystitis and 40 of PCG. Statistical comparisons of immunostaining results with clinical and pathological features were performed. The results showed that the percentages of detectable bcl-2 expression shown in PCG (77.5%) and adjacent dysplastic lesions were significantly higher than that in cholecystitis (P < 0.05). Enhanced bcl-2 expression in PCG wasn't correlated with histological subtypes, sex, age, complicated gallstones and stage, but with grading. The percentage of detectable bax expression shown in cholecystitis was significantly higher than that in PCG (0.025 < P < 0.05). The positive rate of bax in adjacent dysplastic lesions was not significantly different from PCG and cholecystitis. The expression of bax in PCG correlate with grade, but not with other clinical and pathological features, bcl-2 is negatively correlated with expression of bax. Apoptosis, especially the bcl-2 gene family, proves likely to be a tumorigenesis factor for PCG.
What problem does this paper attempt to address?